KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in LLY — ELI LILLY & Co
CIK 1021223
LOS ANGELES, CA
Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$78,368,363
+$12,424,534 QoQ
Shares Held
65,338
-8.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#430
of 4,604 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 32%
Shared 67%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. LLY ranks #1 (52.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
65,338 | $78,368,363 | |
| 2 | ABBV |
AbbVie Inc.
|
113,217 | $28,489,925 | |
| 3 | JNJ |
Johnson & Johnson
|
57,018 | $14,480,861 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,634 | $8,305,469 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
50,176 | $6,339,235 | |
| 6 | AMGN |
Amgen Inc
|
11,431 | $4,139,392 | |
| 7 | AZN |
Astrazeneca PLC
|
21,789 | $4,131,630 | |
| 8 | NVO |
Novo Nordisk A S
|
28,829 | $1,382,062 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,368,363 | 65,338 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $65,943,829 | 71,696 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $88,048,540 | 81,930 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $72,145,465 | 94,555 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $65,438,425 | 83,946 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $63,728,040 | 77,161 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $75,070,125 | 84,735 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $77,828,275 | 85,962 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $69,571,406 | 89,428 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $53,249,158 | 91,349 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $50,575,086 | 94,158 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $45,631,284 | 97,299 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $22,537,966 | 65,628 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $24,741,759 | 67,630 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $701,633 | 2,164 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $654,641 | 2,286 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $540,838 | 1,958 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $449,854 | 1,947 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $434,251 | 1,892 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $390,827 | 2,092 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $353,213 | 2,092 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $309,657 | 2,092 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $112,627 | 686 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $67,417 | 486 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||